The prognostic value of perioperative, pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancer Article

May, Taymaa, Stewart, Jocelyn M, Bernardini, Marcus Q et al. (2018). The prognostic value of perioperative, pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancer . INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 140(2), 247-252. 10.1002/ijgo.12376

International Collaboration

cited authors

  • May, Taymaa; Stewart, Jocelyn M; Bernardini, Marcus Q; Ferguson, Sarah E; Laframboise, Stephane; Jiang, Haiyan; Rosen, Barry

sustainable development goals

authors

publication date

  • February 1, 2018

published in

keywords

  • CA125
  • EARLY CHEMOTHERAPY
  • High-grade serous carcinoma
  • Life Sciences & Biomedicine
  • MONOCLONAL-ANTIBODY
  • Obstetrics & Gynecology
  • Ovarian neoplasm
  • Overall survival
  • PREOPERATIVE SERUM CA-125
  • Prognostic indicator
  • SURVIVAL
  • Science & Technology
  • Tumor marker

Digital Object Identifier (DOI)

publisher

  • WILEY

start page

  • 247

end page

  • 252

volume

  • 140

issue

  • 2